|
Market Closed -
Other stock markets
|
After hours 21:16:15 | |||
| 529.65 USD | +1.10% |
|
530.00 | +0.07% |
| Market Cap | 133B 115B 108B 98.3B 185B 12,665B 188B 1,263B 495B 6,339B 499B 488B 21,149B | P/E 2026 * |
30.9x | P/E 2027 * | 25.4x |
|---|---|---|---|---|---|
| Enterprise Value | 119B 103B 96.18B 87.76B 165B 11,307B 168B 1,128B 442B 5,660B 445B 435B 18,881B | EV / Sales 2026 * |
8.99x | EV / Sales 2027 * | 7.84x |
| Free-Float |
99.79% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Vertex Pharmaceuticals Incorporated
| 1 day | +1.08% | ||
| 1 week | +10.63% | ||
| Current month | +11.00% | ||
| 1 month | +10.27% | ||
| 3 months | +21.69% | ||
| 6 months | +14.82% | ||
| Current year | +16.81% |
| 1 week | 479.02 | 546.17 | |
| 1 month | 465 | 546.17 | |
| Current year | 412.27 | 546.17 | |
| 1 year | 374.17 | 546.17 | |
| 3 years | 340.83 | 546.17 | |
| 5 years | 176.36 | 546.17 | |
| 10 years | 71.46 | 546.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 31/03/2020 | |
Charles Wagner
DFI | Director of Finance/CFO | 57 | 09/04/2019 |
Sean Daughtry
CTO | Chief Tech/Sci/R&D Officer | - | 29/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Sachs
BRD | Director/Board Member | 66 | 31/12/1997 |
Jeffrey Leiden
CHM | Chairman | 70 | 30/04/2012 |
Sangeeta Bhatia
BRD | Director/Board Member | 57 | 17/06/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/07/26 | Free | General Counsel | 8,251 | 0.0033% | ||
| 21/07/26 | Free | Public Communications Manager | 8,251 | 0.0033% | ||
| 15/07/26 | Free | Director | 100 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.10% | +10.63% | +41.42% | +51.37% | 133B | ||
| -1.68% | +8.55% | +90.65% | +129.25% | 1,098B | ||
| -0.60% | +1.62% | +49.03% | +49.01% | 631B | ||
| +0.88% | +2.28% | +25.54% | +63.86% | 438B | ||
| -1.13% | +3.13% | +49.78% | +39.13% | 368B | ||
| -0.74% | +1.01% | +31.08% | +38.64% | 298B | ||
| -1.22% | +2.99% | +8.44% | +6.11% | 251B | ||
| -0.65% | +6.18% | +45.26% | +57.75% | 226B | ||
| +0.34% | -0.13% | -4.77% | -50.50% | 209B | ||
| +3.11% | +0.42% | +12.74% | +69.78% | 165B | ||
| Average | -0.05% | +1,540.84% | +34.92% | +45.44% | 381.71B | |
| Weighted average by Cap. | -0.57% | +1,302.35% | +49.30% | +65.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 13.19B 11.43B 10.7B 9.76B 18.37B 1,258B 18.68B 125B 49.16B 630B 49.52B 48.44B 2,101B | 14.58B 12.64B 11.83B 10.8B 20.32B 1,391B 20.66B 139B 54.36B 696B 54.76B 53.57B 2,323B |
| Net income | 4.32B 3.74B 3.5B 3.2B 6.01B 412B 6.11B 41.06B 16.09B 206B 16.21B 15.85B 687B | 5.21B 4.52B 4.23B 3.86B 7.26B 497B 7.38B 49.6B 19.43B 249B 19.58B 19.15B 830B |
| Net Debt | -14.24B -12.34B -11.55B -10.54B -19.84B -1,358B -20.17B -135B -53.08B -680B -53.47B -52.31B -2,268B | -18.44B -15.98B -14.96B -13.65B -25.68B -1,759B -26.11B -175B -68.72B -880B -69.23B -67.72B -2,937B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/08/26 | US$529.65 | +1.10% | 1,064,630 |
| 10/08/26 | US$523.91 | +5.61% | 2,682,319 |
| 07/08/26 | US$496.07 | +2.49% | 992,491 |
| 06/08/26 | US$484.03 | -0.17% | 1,015,131 |
| 05/08/26 | US$484.83 | +1.28% | 1,383,067 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VRTX Stock
Select your edition
All financial news and data tailored to specific country editions

















